Please login to the form below

Not currently logged in
Email:
Password:

amphetamine and dextroamphetamine

This page shows the latest amphetamine and dextroamphetamine news and features for those working in and with pharma, biotech and healthcare.

Shire weathers generic Adderall XR challenge

Shire weathers generic Adderall XR challenge

Shire posted revenue growth of 5 per cent for the fourth quarter of 2012 despite facing full generic competition for its attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and ... dextroamphetamine). Authorised generics of

Latest news

  • FDA issues counterfeit Adderall warning

    Legitimate versions of Adderall should contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate. ... Rogue websites and distributors may especially target medicines in short supply for

  • Shire's once-daily ADHD drug Venvanse accepted for European review

    If approved it would become the first amphetamine-based drug to be licensed for attention deficit hyperactivity disorder (ADHD) in Europe, where Shire has been working to overcome scepticism of the ... In addition to Venvanse, Shire's ADHD portfolio

  • Shire's Q3 net profit doubles

    Shire's Q3 net profit doubles. Net profit for Shire recovers from payment to Acceleron and impairment charges relating to the divestment of Daytrana. ... Products that performed particularly well in the quarter included ADHD treatments Vyvanse

  • Shire ADHD scholarship programme

    Applicants' work experience, volunteer/extracurricular activities, and academic transcripts will also be taken into account. ... use as adjunctive therapy to stimulants; the extended-release drug Vyvanse (lisdexamfetamine dimesylate), which was approved

  • New use cleared for Shire ADHD drug

    The company's ADHD portfolio also includes the extended-release drug VyVanse (lisdexamfetamine dimesylate), which was approved in the US in 2007, and Adderall XR (dextroamphetamine and amphetamine), which was approved ... in 2001 and has patent

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics